Clinical Trials Insight: 700030263

Trial Profile

Clinical Trials Insight: 700030263

Phase of Trial: Phase I

Latest Information Update: 28 Sep 2010

At a glance

  • Drugs AFP 464 (Primary)
  • Indications Solid tumours
  • Focus Adverse reactions
  • Sponsors Kirax Corporation
  • Most Recent Events

    • 28 Sep 2010 Status changed from recruiting to completed according to a Tigris Pharmaceuticals media release.
    • 01 Feb 2008 New trial record.
    • 30 Jan 2008 The first patient was dosed in December and enrolment is ongoing; reported in a Tigris media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top